LAUSANNE, Switzerland--(BUSINESS WIRE)--May 2, 2019--
MEDIA ADVISORY
What: André Calantzopoulos, Chief Executive Officer of
Philip Morris International Inc. (PMI), will address Boston’s business
community and leaders during an invitation-only event at the Boston
College Chief Executives Club, a long-recognized forum for conversation
and connection. The speech comes days after the U.S. Food and Drug
Administration confirmed that IQOS, PMI’s electrically heated
tobacco system, is appropriate for the protection of public health and
authorized it for sale in the U.S.
Calantzopoulos will present the extended efforts PMI is making to
replace cigarettes with a portfolio of revolutionary products and engage
with the area’s leading business representatives in a call to action to
unsmoke the world.
Just as Boston’s private and state sectors prioritized their investment
behind positive social change to build a culture rich in academics,
health and wellness, and innovation, PMI has invested significantly in
scientific research, product development and manufacturing facilities—to
the value of over $6 billion USD as of December 31, 2018—to transform
the public health landscape of tomorrow.
When: May 3, 2019
12:00 pm (noon) EST
Where: Wharf Room, Boston Harbor Hotel
70 Rowes Wharf
Boston, MA 02110
Who: André Calantzopoulos, Chief Executive Officer, Philip Morris
International Inc.
About Philip Morris International: Delivering a Smoke-Free Future
Philip Morris International (PMI) is leading a transformation in the
tobacco industry to create a smoke-free future and ultimately replace
cigarettes with smoke-free products to the benefit of adults who would
otherwise continue to smoke, society, the company and its shareholders.
PMI is a leading international tobacco company engaged in the
manufacture and sale of cigarettes, smoke-free products and associated
electronic devices and accessories, and other nicotine-containing
products in markets outside the U.S. PMI is building a future on a new
category of smoke-free products that, while not risk-free, are a much
better choice than continuing to smoke. Through multidisciplinary
capabilities in product development, state-of-the-art facilities and
scientific substantiation, PMI aims to ensure that its smoke-free
products meet adult consumer preferences and rigorous regulatory
requirements. PMI's smoke-free IQOS product portfolio includes
heat-not-burn and nicotine-containing vapor products. As of March 31,
2019, PMI estimates that approximately 7.3 million adult smokers around
the world have already stopped smoking and switched to PMI’s
heat-not-burn product, which is currently available for sale in 47
markets in key cities or nationwide under the IQOS brand. For
more information, please visit www.pmi.com
and www.pmiscience.com.
For further information about the U.S. Food and Drug Administration
announcement, please visit: https://www.businesswire.com/news/home/20190430006048/en/Philip-Morris-International-Announces-U.S.-Food-Drug
View source version on businesswire.com: https://www.businesswire.com/news/home/20190502005485/en/
Source: Philip Morris International
Corey Henry
Philip Morris International Media Office
T.
+1.202.679.7296
E. corey.henry@pmi.com
